Inventor · disambiguated record
Wing-Pui Kong
Also filed as: KONG WING-PUI
19 granted patents·15 pending applications·75 citations·filing 2005–2025
93Inventor score
Top patents by PatentIndex Score
34 records- 0196US10301377B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2016·Granted May 28, 2019·24 cites·23 claims
- 0293US11878998B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2021·Granted Jan 23, 2024·2 cites·27 claims
- 0393US8323961B2HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIVNABEL GARY J·Filed 2011·Granted Dec 4, 2012·13 cites·2 claims
- 0492US11370828B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Jun 28, 2022·9 cites·30 claims
- 0592US7947822B2HIV vaccines based on Env of multiple clades of HIVUS HEALTH·Filed 2010·Granted May 24, 2011·17 cites·3 claims
- 0691US11447541B1Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Sep 20, 2022·3 cites·26 claims
- 0788US12435113B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2023·Granted Oct 7, 2025·0 cites·27 claims
- 0887US12275758B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2024·Granted Apr 15, 2025·0 cites·29 claims
- 0986US11174292B2Substitutions-modified prefusion RSV F proteins and their useUS HEALTH·Filed 2017·Granted Nov 16, 2021·2 cites·35 claims
- 1084US11602559B2HIV-1 Env fusion peptide immunogens and their useUS HEALTH·Filed 2017·Granted Mar 14, 2023·2 cites·16 claims
- 1181US11078239B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2017·Granted Aug 3, 2021·1 cites·24 claims
- 1278US12458691B2HIV-1 ENV fusion peptide immunogens and their useUS HEALTH·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 1377US11845778B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 1476US12172038B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·25 claims
- 1573US10898566B2Zika virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Jan 26, 2021·2 cites·20 claims
- 1673US2009286860A1Method of using adenoviral vectors to induce an immune responseGENVEC INC·Filed 2009·Application pending·0 cites
- 1770US2025388627A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 1865US7666427B2HIV vaccines based on Env of multiple clades of HIVUS HEALTH·Filed 2007·Granted Feb 23, 2010·0 cites·42 claims
- 1965US2023242593A1Zika viral antigen constructsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 2064US2022356229A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 2163US2021292393A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 2261US2007207166A1Method of Using Adenoviral Vectors to Induce an Immune ResponseGENVEC INC·Filed 2005·Application pending·0 cites
- 2360US10759846B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2019·Granted Sep 1, 2020·0 cites·26 claims
- 2460US2025000968A1Sars-cov-2 spike fused to a hepatitis b surface antigenTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2022·Application pending·0 cites
- 2558US2010074916A1Avian influenza vaccineUS GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 2657US2024299510A1Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteinsUS HEALTH·Filed 2021·Application pending·0 cites
- 2757US2012302627A1Method of using adenoviral vectors to induce an immune responseNABEL GARY J·Filed 2012·Application pending·0 cites
- 2856US2006275897A1HIV vaccines based on Env of multiple clades of HIVNABEL GARY J·Filed 2006·Application pending·0 cites
- 2955US12053519B2HIV-1 Env fusion peptide nanoparticle carrier conjugates and their useUS HEALTH·Filed 2019·Granted Aug 6, 2024·0 cites·16 claims
- 3055US11780885B2Zika viral antigen constructsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Oct 10, 2023·0 cites·19 claims
- 3152US2023174587A1Recombinant human metapneumovirus f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2021·Application pending·0 cites
- 3246US2009208531A1Antiviral agents and vaccines against influenzaNAT INST HEALTH·Filed 2007·Application pending·0 cites
- 3343US2011171260A1Influenza dna vaccination and methods of use thereofUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2010·Application pending·0 cites
- 3441US2012219583A1Nucleic acid sequences encoding expandable hiv mosaic proteinsNABEL GARY J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wing-Pui Kong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →